Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain Research

• Publication date

  2016-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.brainres.2016.09.025PMID 27659966PMCID PMC5085862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of aging on glutamate neurotransmission in the substantia nigra of Gdnf heterozygous mice.

  2015cited by this paper
• Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease

  2015cited by this paper
• L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history.

  2015cited by this paper
• Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice

  2015cited by this paper
• Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease.

  2015cited by this paper
• Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias.

  2014cited by this paper
• Neuronal activity (c-Fos) delineating interactions of the cerebral cortex and basal ganglia

  2014cited by this paper
• Astrocytic Dysfunction and Addiction

  2014cited by this paper
• Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

  2013cited by this paper
• Role of the Major Glutamate Transporter GLT1 in Nucleus Accumbens Core Versus Shell in Cue-Induced Cocaine-Seeking Behavior

  2013cited by this paper
• An allosteric modulator of metabotropic glutamate receptors (mGluR2), (+)‐TFMPIP, inhibits restraint stress‐induced phasic glutamate release in rat prefrontal cortex

  2012cited by this paper
• Synaptic dysfunction in Parkinson's disease.

  2012cited by this paper
• Molecular basis of NMDA receptor functional diversity

  2011cited by this paper
• Metabotropic glutamate receptors: from the workbench to the bedside.

  2011cited by this paper
• Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease

  2011cited by this paper
• Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: basic characterization and drug pharmacology.

  2011cited by this paper
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

  2011cited by this paper
• Metabotropic glutamate receptors: physiology, pharmacology, and disease.

  2010cited by this paper
• Genetic animal models of Parkinson's disease.

  2010cited by this paper
• MitoPark mice mirror the slow progression of key symptoms and L‐DOPA response in Parkinson's disease

  2010cited by this paper
• An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease.

  2010cited by this paper
• Molecular dissection of reactive astrogliosis and glial scar formation.

  2009influential reference
• Second-by-Second Measures of l-Glutamate in the Prefrontal Cortex and Striatum of Freely Moving Mice

  2008cited by this paper
• Chronic stress enhances methamphetamine‐induced extracellular glutamate and excitotoxicity in the rat striatum

  2008cited by this paper
• Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons

  2007cited by this paper
• Second-by-Second Measures of L-Glutamate and Other Neurotransmitters Using Enzyme-Based Microelectrode Arrays -- Electrochemical Methods for Neuroscience

  2007cited by this paper
• Principles, Development and Applications of Self-Referencing Electrochemical Microelectrodes to the Determination of Fluxes at Cell Membranes

  2007cited by this paper
• Second-by-Second Measures of L-Glutamate and Other Neurotransmitters Using Enzyme-Based Microelectrode Arrays

  2007influential reference
• Acrolein produces nitric oxide through the elevation of intracellular calcium levels to induce apoptosis in human umbilical vein endothelial cells: implications for smoke angiopathy.

  2006cited by this paper
• Characterization of a mouse strain expressing Cre recombinase from the 3′ untranslated region of the dopamine transporter locus

  2006cited by this paper
• A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra.

  2006cited by this paper
• Microelectrode array studies of basal and potassium‐evoked release of l‐glutamate in the anesthetized rat brain

  2006cited by this paper
• Glial glutamate transporter expression patterns in brains from multiple mammalian species

  2005cited by this paper
• Repeated amphetamine treatment causes a persistent elevation of glial fibrillary acidic protein in the caudate-putamen.

  2004cited by this paper
• Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

  2004cited by this paper
• Group I Metabotropic Glutamate Receptors in the Monkey Striatum: Subsynaptic Association with Glutamatergic and Dopaminergic Afferents

  2003cited by this paper
• The mouse brain in stereotaxic coordinates

  2003influential reference
• Improved ceramic-based multisite microelectrode for rapid measurements of L-glutamate in the CNS.

  2002cited by this paper
• Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity?

  2000cited by this paper
• Microcircuitry of the direct and indirect pathways of the basal ganglia.

  1998cited by this paper
• In Vivo Electrochemical Studies of Dopamine Clearance in the Rat Substantia Nigra: Effects of Locally Applied Uptake Inhibitors and Unilateral 6‐Hydroxydopamine Lesions

  1998cited by this paper
• Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice

  1998cited by this paper
• Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis.

  1996cited by this paper
• Synaptopathies: Dysfunction of Synaptic Function Synaptic Dysfunction in Parkinson's Disease

  year unknowncited by this paper

• Effects of exercise training on the nigrostriatal glutamatergic pathway and receptor interactions in Parkinson’s disease: a systematic review

  2025cites this paper
• Therapeutic Viewpoint on Rat Models of Locomotion Abnormalities and Neurobiological Indicators in Parkinson's Disease.

  2023cites this paper
• A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology

  2022cites this paper
• Sensitive and Low-Bias Transcriptome Sequencing Using Agarose PCR.

  2022cites this paper
• Deletion of RE1‐silencing transcription factor in striatal astrocytes exacerbates manganese‐induced neurotoxicity in mice

  2022cites this paper
• Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.

  2021cites this paper
• Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease.

  2021cites this paper
• Exercise increases striatal Glu reuptake and improves motor dysfunction in 6-OHDA-induced Parkinson’s disease rats

  2021cites this paper
• Paraquat-induced intracellular Zn2+ dysregulation causes dopaminergic degeneration in the substantia nigra, but not in the striatum.

  2021cites this paper
• Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.

  2020cites this paper
• Characterization of Nonmotor Symptoms in the MitoPark Mouse Model of Parkinson’s Disease

  2020cites this paper
• Heterogeneity of dopamine release sites in health and degeneration.

  2019cites this paper
• PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson’s Disease

  2019cites this paper
• 5‐HT1F receptor‐mediated mitochondrial biogenesis for the treatment of Parkinson's disease

  2018cites this paper
• Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice

  2018cites this paper